Eton Pharmaceuticals (ETON) Total Non-Current Liabilities (2023 - 2025)
Historic Total Non-Current Liabilities for Eton Pharmaceuticals (ETON) over the last 3 years, with Q3 2025 value amounting to $76.2 million.
- Eton Pharmaceuticals' Total Non-Current Liabilities changed N/A to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year change of. This contributed to the annual value of $49.9 million for FY2024, which is 20661.62% up from last year.
- According to the latest figures from Q3 2025, Eton Pharmaceuticals' Total Non-Current Liabilities is $76.2 million.
- Eton Pharmaceuticals' 5-year Total Non-Current Liabilities high stood at $76.2 million for Q3 2025, and its period low was $16.3 million during Q4 2023.
- In the last 3 years, Eton Pharmaceuticals' Total Non-Current Liabilities had a median value of $55.4 million in 2025 and averaged $53.7 million.
- Examining YoY changes over the last 5 years, Eton Pharmaceuticals' Total Non-Current Liabilities showed a top increase of 20661.62% in 2024 and a maximum decrease of 20661.62% in 2024.
- Over the past 3 years, Eton Pharmaceuticals' Total Non-Current Liabilities (Quarter) stood at $16.3 million in 2023, then soared by 206.62% to $49.9 million in 2024, then surged by 52.8% to $76.2 million in 2025.
- Its Total Non-Current Liabilities stands at $76.2 million for Q3 2025, versus $70.8 million for Q2 2025 and $55.4 million for Q1 2025.